Glycosylation is one of the major post-translational modifications, required for proper folding and functions of glycoproteins. N-glycosylation in ER is mediated by oligosaccharyltransferase (OST), an enzyme complex transferring preassembled oligosaccharide to asparagine residues of nascent polypeptide chain. Our study here indicates that regulator of calcineurin 1 (RCAN1) can enhance N-glycosylation in ER, therefore elevates the activities of β- and γ-secretase and markedly increases Aβ production. We found that RCAN1 stabilizes OST by interacting with OST component ribophorinI (RPN I). RCAN1 enhanced glycosylation of membrane proteins and glycosylation sequon GNSTVT, but has no effect on transferrin whose glycosylation was only affected by OST catalytic subunit STT3A, suggesting the effect of RCAN1 is associated with RPN I in facilitating substrate delivery. Our previous studies have shown that RCAN1 was increased in AD brains and RCAN1 overexpression induced neuronal apoptosis. Here our study showed that RCAN1 further contributes to AD pathogenesis by increasing N-glycosylation and Aβ production.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1567205011666140331225855DOI Listing

Publication Analysis

Top Keywords

rcan1
8
increases aβ
8
aβ production
8
rcan1 increases
4
aβ generation
4
generation promoting
4
n-glycosylation
4
promoting n-glycosylation
4
n-glycosylation oligosaccharyltransferase
4
glycosylation
4

Similar Publications

Gastric cancer (GC) is one of the most prevalent malignant tumors in the world and has an extremely poor prognosis. Regulator of calcineurin 1 (RCAN1), a known tumor suppressor in various cancers, has an undefined role in the proliferation and metastasis of GC. Primary tumor and paired normal gastric tissues were collected from 77 patients with GC for evaluating the mRNA levels of 3 RCAN1 transcripts.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoarthritis (OA) is a joint disease characterized by calcification in cartilage, and this study seeks to understand the mechanisms behind this process to help develop new treatments.
  • Researchers stimulated chondrocytes with calciprotein particles to analyze changes in gene expression, identifying 1466 modulated genes and confirming 27 of them as relevant to OA from existing human data.
  • Key findings revealed two gene families influenced by calciprotein particles, including cytoskeletal and extracellular matrix genes, which could provide new therapeutic targets for treating OA.
View Article and Find Full Text PDF

Progressive metastasis is the primary cause of cancer-related deaths. It has been recognized that many cancers are characterized by long periods of stability followed by subsequent progression. Genes termed metastasis progression suppressors (MPS) are functional gatekeepers of this process, and their loss leads to late-stage progression.

View Article and Find Full Text PDF

Causal inference of the effect of plasma proteins on the incidence of oral cancer: two-sample Mendelian randomization.

BMC Oral Health

September 2024

Stomatological Hospital, School of Stomatology, Southern Medical University, S366 Jiangnan Boulevard, Haizhu District, Guangzhou City, 510280, Guangdong Province, China.

Objective: This study is aimed to investigate the causal relationship between plasma proteins and oral cancer risk using two-sample MR (Mendelian randomization).

Methods: Summary-level GWAS (genome-wide association study) data on plasma protein levels (4,907 proteins) and oral cancer (6,034 cases, 6,585 controls) of European ancestry were utilized. SNPs (single nucleotide polymorphisms) associated with proteins at genome-wide significance were selected as instrumental variables.

View Article and Find Full Text PDF

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin.

FEBS J

November 2024

Institute of Molecular Enzymology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.

Calcineurin is a serine/threonine protein phosphatase that is highly conserved from yeast to human and plays a critical role in many physiological processes. Regulators of calcineurin (RCANs) are a family of endogenous calcineurin regulators, which are capable of inhibiting the catalytic activity of calcineurin in vivo and in vitro. In this study, we first characterized the biochemical properties of yeast calcineurin and its endogenous regulator Rcn1, a yeast homolog of RCAN1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!